New Enterprise Associates

Spiras Health operates a healthcare service that delivers specialized care to patients' homes for those managing complex chronic conditions. Their multidisciplinary clinical team offers services enhanced by telehealth, digital communications, and remote monitoring, aiming to improve patients' quality of life and reduce unnecessary hospitalizations.

Amplyx Pharmaceuticals, Inc. is a small molecule drug development company focused on creating innovative therapies for debilitating and life-threatening diseases, particularly those affecting individuals with compromised immune systems. Founded in 2006 and based in San Diego, California, the company specializes in the development of oral and injectable anti-infective drugs, including antifungal agents designed to treat invasive fungal infections caused by pathogens such as Candida and Aspergillus. Amplyx employs a unique platform approach that enhances the efficacy and reduces the toxicity of existing drugs by incorporating a second small molecule. This strategy aims to provide effective treatment options for patients undergoing chemotherapy and other immunosuppressive therapies, ensuring they receive appropriate care both during hospitalization and after discharge.

Vesper Medical, Inc. is a medical device company based in Wayne, Pennsylvania, founded in 2016. The company specializes in the development of minimally invasive peripheral vascular products aimed at treating patients with deep venous disease. Its primary offering is the Vesper DUO Venous Stent System, designed specifically for venous stenting. This system features a unique combination of strength and flexibility to address the complex anatomical challenges encountered in the iliac and femoral veins. Vesper Medical is dedicated to creating safe, effective, and user-friendly products that enhance patient care and support healthcare providers in improving patient outcomes in venous treatment.

CPS is a leading provider of hospital solutions, specializing in transforming operations to enhance patient care. They deliver expert services including pharmacy management, rehabilitation support, supply chain optimization, and material management to healthcare organizations.

Founded in 2009, Lungpacer Medical is a medical device company based in Vancouver, Canada. It specializes in developing therapeutic solutions to preserve and restore the strength of the diaphragm muscle in critically ill patients requiring mechanical ventilation. The company's flagship product, the Lungpacer DPT System, uses a minimally invasive, transvascular nerve stimulation approach to activate the diaphragm, potentially improving patient outcomes and reducing hospital care costs.

Vesper Medical, Inc. is a medical device company based in Wayne, Pennsylvania, founded in 2016. The company specializes in the development of minimally invasive peripheral vascular products aimed at treating patients with deep venous disease. Its primary offering is the Vesper DUO Venous Stent System, designed specifically for venous stenting. This system features a unique combination of strength and flexibility to address the complex anatomical challenges encountered in the iliac and femoral veins. Vesper Medical is dedicated to creating safe, effective, and user-friendly products that enhance patient care and support healthcare providers in improving patient outcomes in venous treatment.

Amplyx Pharmaceuticals, Inc. is a small molecule drug development company focused on creating innovative therapies for debilitating and life-threatening diseases, particularly those affecting individuals with compromised immune systems. Founded in 2006 and based in San Diego, California, the company specializes in the development of oral and injectable anti-infective drugs, including antifungal agents designed to treat invasive fungal infections caused by pathogens such as Candida and Aspergillus. Amplyx employs a unique platform approach that enhances the efficacy and reduces the toxicity of existing drugs by incorporating a second small molecule. This strategy aims to provide effective treatment options for patients undergoing chemotherapy and other immunosuppressive therapies, ensuring they receive appropriate care both during hospitalization and after discharge.

Amplyx Pharmaceuticals, Inc. is a small molecule drug development company focused on creating innovative therapies for debilitating and life-threatening diseases, particularly those affecting individuals with compromised immune systems. Founded in 2006 and based in San Diego, California, the company specializes in the development of oral and injectable anti-infective drugs, including antifungal agents designed to treat invasive fungal infections caused by pathogens such as Candida and Aspergillus. Amplyx employs a unique platform approach that enhances the efficacy and reduces the toxicity of existing drugs by incorporating a second small molecule. This strategy aims to provide effective treatment options for patients undergoing chemotherapy and other immunosuppressive therapies, ensuring they receive appropriate care both during hospitalization and after discharge.

Nova Specialty Hospitals (formerly Nova Specialty Surgery) is a fully equipped medical facility located conveniently in your neighborhood. It brings cutting edge medical technology and internationally trained physicians under one roof to give patients easy access to quality, affordable healthcare. Nova's medical services are based on the out-patient care model that enables quicker diagnosis and reduces patients' recovery time. This healthcare delivery system optimizes our staff's efficiency while reducing operational costs, thereby providing incomparable value and convenience to our patients.

NephroPlus operates a network of dialysis centers dedicated to delivering quality renal care at affordable prices through standardized protocols, continuous staff training, and focused process innovation. The network provides dialysis services and related treatments such as kidney stone management and arteriovenous fistula procedures, along with other renal and urological care, enabling patients to access specialized treatment and improve recovery.

DSI Renal is a prominent provider of dialysis services in the United States, catering to patients with chronic kidney failure. The company operates healthcare centers focused on delivering comprehensive dialysis care, patient support, and assistance for individuals traveling with dialysis needs. DSI Renal aims to enhance its presence through strategic acquisitions, the development of new clinics, and organic growth initiatives, ensuring that it meets the evolving needs of patients diagnosed with kidney disease.

ESP Pharma is a hospital-focused pharmaceutical company that specializes in acquiring and enhancing the marketing of approved specialty therapeutics and late-stage development drugs. The company provides innovative therapeutics primarily for high blood pressure, angina, and bone marrow transplants, targeting physicians, hospitals, and acute-care patients. By focusing on specialty pharmaceutical products, ESP Pharma aims to improve the quality of care available to healthcare professionals and enhance patient outcomes in acute-care settings.

Encompass Health Corporation is a leading provider of facility-based and home-based post-acute healthcare services in the United States. The company operates primarily through two segments: Inpatient Rehabilitation and Home Health and Hospice. The Inpatient Rehabilitation segment offers specialized rehabilitative treatment for patients recovering from a variety of conditions, including strokes, neurological disorders, cardiac and pulmonary issues, and complex orthopedic conditions. In contrast, the Home Health and Hospice segment delivers a range of Medicare-certified services, including skilled nursing, therapy, and hospice care, primarily in the Southeast and Texas. As of November 2020, Encompass Health operated 137 hospitals, 242 home health locations, and 83 hospice sites across 39 states and Puerto Rico. Founded in 1983 and headquartered in Birmingham, Alabama, the company was previously known as HealthSouth Corporation before rebranding in January 2018.